has added a slew of new stocks to its coverage, ranging from tech companies to health care firms and media businesses. Of the more than 70 stocks it started researching in July, it is buy-rated on about 45 — and some have a potential upside of over 100%.
Pro
Pro
Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação: